Robert Weil, CNRS research director and head of the “Signaling and Pathogenesis” team at the Center for Immunology and Infectious Diseases (CIMI), is working on auranofine. Auranofine is one of the few drugs to have an effect on both virus infection and the inflammation it causes. The team is studying the mechanisms by which this compound controls virus replication and inflammation, and re-establishes a natural defense mechanism against the virus.
In partnership with the Solvay Solidarity Fund, the Foundation supports Robert Weil’s work.
